HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Cutaneous Administration

The application of suitable drug dosage forms to the skin for either local or systemic effects.
Also Known As:
Administration, Cutaneous; Administration, Dermal; Administration, Transcutaneous; Administration, Transdermal; Cutaneous Administration, Drug; Dermal Administration; Drug Administration, Cutaneous; Skin Administration, Drug; Administration, Cutaneous Drug; Administration, Dermal Drug; Administration, Percutaneous; Administrations, Cutaneous; Administrations, Cutaneous Drug; Administrations, Dermal; Administrations, Dermal Drug; Administrations, Percutaneous; Administrations, Transcutaneous; Administrations, Transdermal; Cutaneous Administrations; Cutaneous Administrations, Drug; Cutaneous Drug Administrations; Dermal Administrations; Dermal Drug Administrations; Drug Administrations, Cutaneous; Drug Administrations, Dermal; Drug Skin Administrations; Percutaneous Administrations; Skin Administrations, Drug; Skin Drug Administrations; Transcutaneous Administrations; Transdermal Administrations; Cutaneous Drug Administration; Dermal Drug Administration; Drug Administration, Dermal; Percutaneous Administration; Skin Drug Administration; Transcutaneous Administration; Transdermal Administration
Networked: 153 relevant articles (15 outcomes, 21 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1. Hajjar, Roger J: 7 articles (02/2014 - 04/2009)
2. Greenberg, Barry: 5 articles (09/2015 - 04/2009)
3. Yaroshinsky, Alex: 3 articles (02/2014 - 07/2011)
4. Zsebo, Krisztina M: 3 articles (02/2014 - 04/2009)
5. Graham, Charles H: 2 articles (02/2014 - 01/2014)
6. Wagner, Kim: 2 articles (02/2014 - 01/2014)
7. Rudy, Jeffrey J: 2 articles (02/2014 - 01/2014)
8. Yerevanian, Armen: 2 articles (02/2014 - 11/2013)
9. Jessup, Mariell: 2 articles (01/2014 - 07/2011)
10. Luo, Guoan: 2 articles (06/2012 - 06/2012)

Related Diseases

1. Pain (Aches)
2. Hypothermia
3. Heart Diseases (Heart Disease)
4. Heart Failure
09/01/2015 - "The Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) study was a Phase 2a double-blind, randomized, placebo-controlled, dose-finding study that was performed in patients with advanced heart failure due to systolic dysfunction. "
02/01/2014 - "Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium up-regulation by percutaneous administration of gene therapy in cardiac disease phase 2b)."
02/01/2014 - "The recent success of the Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease phase 2 trials using adeno-associated virus 1-SERCA2a in improving outcomes highlights the importance of gene therapy as a future tool in treating congestive heart failure."
04/01/2012 - "Use of gene therapy for heart failure is gaining momentum as a result of the recent successful completion of phase II of the Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID) trial, which showed clinical safety and efficacy of an adeno-associated viral vector expressing sarco-endoplasmic reticulum calcium ATPase (SERCA2a). "
01/03/2014 - "The Calcium Up-Regulation by Percutaneous Administration of Gene Therapy In Cardiac Disease (CUPID 1) study was a phase 1/phase 2 first-in-human clinical gene therapy trial using an adeno-associated virus serotype 1 (AAV1) vector carrying the sarcoplasmic reticulum calcium ATPase gene (AAV1/SERCA2a) in patients with advanced heart failure. "
5. Postmenopausal Osteoporosis

Related Drugs and Biologics

1. Morphine (MS Contin)
2. Opioid Analgesics (Opioids)
3. Calcium
4. Calcium-Transporting ATPases (Ca2+ ATPase)
5. rivastigmine (Exelon)
6. Estrogen Receptor Modulators (Antiestrogen)
7. Oxygen
8. Methimazole (Thiamazole)
9. Isoflurane
10. Hormones

Related Therapies and Procedures

1. Anesthesia
2. Inhalation Anesthesia
3. Estrogen Replacement Therapy
4. Transdermal Patch
5. Oral Administration